Belize vs Latvia: Share of people with HIV who receive antiretroviral therapy
Belize
50.0%
in 2024
Latvia
52.0%
in 2024
Belize rank
120th
Latvia rank
117th
Share of people with HIV who receive antiretroviral therapy over time
- Belize
- Latvia
How they compare
Latvia currently reports 52.0% against 50.0% in Belize, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Latvia ahead.
Belize ranks 120th and Latvia ranks 117th of 143 countries.
Across the 3 decades both report, Belize averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Belize | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.2% | 3.2% | 7.0% | Belize |
| 2010s | 34.9% | 22.0% | 12.9% | Belize |
| 2020s | 44.8% | 49.8% | 5.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Belize or Latvia?
- Latvia, at 52.0% against 50.0% in Belize as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Belize and Latvia?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Belize and Latvia?
- 25 years are reported by both, from 2000 to 2024.
- How do Belize and Latvia rank globally for share of people with hiv who receive antiretroviral therapy?
- Belize ranks 120th and Latvia ranks 117th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.